Disparities in disease presentation in the four screenable cancers according to health insurance status

Public Health

Volumn 138, Issue , 2016, Pages 50-56

  Amini, A ^a   Jones, B L ^a   Yeh, N ^a   Guntupalli, S R ^a   Kavanagh, B D ^a   Karam, S D ^a   Fisher, C M ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Colorado Department of Public Health Breast and Cervical Cancer Screening and Prevention Advisory Board ^*  (United States)

Author keywords

Affordable Care Act (ACA); Cancer screening; Disparities; Health insurance; SEER

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

CANCER; HEALTH INSURANCE; INVENTORY; MULTIVARIATE ANALYSIS; PUBLIC HEALTH;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; FEMALE; GLEASON SCORE; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PROSTATE CANCER; TUMOR INVASION; UTERINE CERVIX CANCER; ADOLESCENT; BREAST TUMOR; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; FACTUAL DATABASE; INSURANCE; MEDICALLY UNINSURED; MIDDLE AGED; NEOPLASM; PATHOLOGY; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTERINE CERVIX TUMOR; YOUNG ADULT;

UNITED STATES;

ADOLESCENT; ADULT; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MEDICALLY UNINSURED; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROSTATIC NEOPLASMS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84963649671     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2016.03.014     Document Type: Article

References (30)

1. 1 Kocher, R., Emanuel, E.J., DeParle, N.-A.M., The affordable care act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med 153 (2010), 536–539.
2. 2 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
3. 3 The Henry J. Kaiser Family Foundation. Health Insurance Coverage in America, 2013. http://kff.org/ [accessed 5.10.15].
4. 4 Ayanian, J.Z., Weissman, J.S., Schneider, E.C., Ginsburg, J.A., Zaslavsky, A.M., Unmet health needs of uninsured adults in the United States. JAMA 284 (2000), 2061–2069.
5. 5 Ioannou, G.N., Chapko, M.K., Dominitz, J.A., Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98 (2003), 2082–2091.
6. 6 Matthews, B.A., Anderson, R.C., Nattinger, A.B., Colorectal cancer screening behavior and health insurance status (United States). Cancer Causes Control 16 (2005), 735–742.
7. 7 Rodriguez, M.A., Ward, L.M., Perez-Stable, E.J., Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med 3 (2005), 235–241.
8. 8 Walker, G.V., Grant, S.R., Guadagnolo, B.A., Hoffman, K.E., Smith, B.D., Koshy, M., et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol 32 (2014), 3118–3125.
9. 9 Arnaud, J.P., Koehl, C., Adloff, M., Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum 23 (1980), 141–144.
10. 10 Oesterling, J.E., Jacobsen, S.J., Klee, G.G., Petterson, K., Piironen, T., Abrahamsson, P.A., et al. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154 (1995), 1090–1095.
11. 11 Edge, S.B., Compton, C.C., The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17 (2010), 1471–1474.
12. 12 Winawer, S.J., Fletcher, R.H., Miller, L., Godlee, F., Stolar, M.H., Mulrow, C.D., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112 (1997), 594–642.
13. 13 Saslow, D., Runowicz, C.D., Solomon, D., Moscicki, A.B., Smith, R.A., Eyre, H.J., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 52 (2002), 342–362.
14. 14 Helvie, M.A., Chang, J.T., Hendrick, R.E., Banerjee, M., Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer. Cancer 120 (2014), 2649–2656.
15. 15 Wood, E., Sallar, A.M., Schechter, M.T., Hogg, R.S., Social inequalities in male mortality amenable to medical intervention in British Columbia. Soc Sci Med 48 (1999), 1751–1758.
16. 16 Carrasquillo, O., Himmelstein, D.U., Woolhandler, S., Bor, D.H., Can Medicaid managed care provide continuity of care to new Medicaid enrollees? An analysis of tenure on Medicaid. Am J Public Health 88 (1998), 464–466.
17. 17 Pollitt, R.A., Clarke, C.A., Shema, S.J., Swetter, S.M., California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Am J Prev Med 35 (2008), 7–13.
18. 18 Wee, C.C., McCarthy, E.P., Phillips, R.S., Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41 (2005), 23–29.
19. 19 Ansell, D., Grabler, P., Whitman, S., Ferrans, C., Burgess-Bishop, J., Murray, L.R., et al. A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes Control 20 (2009), 1681–1688.
20. 20 Yu, X.Q., Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race. BMC Cancer, 9, 2009, 364.
21. 21 Hershman, D.L., Tsui, J., Wright, J.D., Coromilas, E.J., Tsai, W.Y., Neugut, A.I., Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33 (2015), 1053–1059.
22. 22 Brawley, O.W., Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94 (2002), 471–473.
23. 23 Ayanian, J.Z., Kohler, B.A., Abe, T., Epstein, A.M., The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329 (1993), 326–331.
24. 24 Gordon, N.H., Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142 (1995), 796–803.
25. 25 Bauer, K.R., Brown, M., Cress, R.D., Parise, C.A., Caggiano, V., Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109 (2007), 1721–1728.
26. 26 Gritz, E.R., Demark-Wahnefried, W., Health behaviors influence cancer survival. J Clin Oncol 27 (2009), 1930–1932.
27. 27 Kobrinsky, N.L., Klug, M.G., Hokanson, P.J., Sjolander, D.E., Burd, L., Impact of smoking on cancer stage at diagnosis. J Clin Oncol 21 (2003), 907–913.
28. 28 Koh, H.K., Sebelius, K.G., Promoting prevention through the affordable care act. N Engl J Med 363 (2010), 1296–1299.
29. 29 Protection, Patient, and Affordable Care Act. Patient protection and affordable care act. Public Law 2010; 111–148.
30. 30 Welch, H.G., Black, W.C., Overdiagnosis in cancer. J Natl Cancer Inst 102 (2010), 605–613.